Research graph
References from Clinical indicators for dose re-optimization in magnetic resonance-guided online adaptive radiotherapy for prostate cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
MR-guidance in clinical reality: current treatment challenges and future perspectives
10.1186/s13014-019-1308-y · 2019 · External reference
MR-guided radiotherapy: the perfect partner for immunotherapy?
2020 · External reference
Adaptive radiotherapy enabled by MRI guidance
10.1016/j.clon.2018.08.001 · 2018 · External reference
Adaptive radiation therapy (ART) strategies and technical considerations: a state of the ART review from NRG oncology
10.1016/j.ijrobp.2020.10.021 · 2021 · External reference
Online magnetic resonance image guided adaptive radiation therapy: first clinical applications
10.1016/j.ijrobp.2015.10.015 · 2016 · External reference
Integrating a 1.5 T MRI scanner with a 6 MV accelerator: proof of concept
10.1088/0031-9155/54/12/n01 · 2009 · External reference
Improving fiducial and prostate capsule visualization for radiotherapy planning using MRI
10.1002/acm2.12529 · 2019 · External reference
Dosimetric implications of computerised tomography-only versus magnetic resonance-fusion contouring in stereotactic body radiotherapy for prostate Cancer
10.3390/medicines5020032 · 2018 · External reference
Dosimetric effects of adaptive prostate cancer radiotherapy in an MR-linac workflow
10.1186/s13014-020-01604-5 · 2020 · External reference
Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
10.1186/1748-717x-8-58 · 2013 · External reference
Identifying risk characteristics using failure mode and effect analysis for risk management in online magnetic resonance-guided adaptive radiation therapy
10.1016/j.phro.2022.06.002 · 2022 · External reference
Adaptive SBRT by 1.5 T MR-linac for prostate cancer: on the accuracy of dose delivery in view of the prolonged session time
10.1016/j.ejmp.2020.09.026 · 2020 · External reference
Automated planning for prostate stereotactic body radiation therapy on the 1.5 T MR-Linac
2022 · External reference
Volume change of the prostate during moderately hypo-fractionated radiotherapy assessed by artificial intelligence
2025 · External reference
Investigation of the changes in the prostate, bladder, and rectal wall sizes during external beam radiotherapy
10.1016/j.rpor.2019.02.005 · 2019 · External reference
Change in prostate volume during extreme hypo-fractionation analysed with MRI
10.1186/1748-717x-9-22 · 2014 · External reference
Prostate volume changes during extreme and moderately hypofractionated magnetic resonance image-guided radiotherapy
10.1016/j.clon.2022.03.022 · 2022 · External reference
Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions on a 1.5T MR-Linac
10.1016/j.radonc.2020.06.044 · 2020 · External reference
NCCN guidelines(R) insights: prostate Cancer, version 3.2024
10.6004/jnccn.2024.0019 · 2024 · External reference
Rectal toxicity of 3-dimensional conformal radiation therapy following hydrogel spacer (space OAR) injection for men with prostate cancer
10.1177/20503121241287086 · 2024 · External reference
Seminal vesicle inter- and intra-fraction motion during radiotherapy for prostate cancer: a review
10.1016/j.radonc.2022.02.002 · 2022 · External reference
Evaluation of a commercial DIR platform for contour propagation in prostate cancer patients treated with IMRT/VMAT
10.1002/acm2.12787 · 2020 · External reference
Daily dosimetric variation between image-guided volumetric modulated arc radiotherapy and MR-guided daily adaptive radiotherapy for prostate cancer stereotactic body radiotherapy
10.1080/0284186x.2020.1821090 · 2021 · External reference
Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: initial clinical experiences and assessment of delivered doses compared to a C-arm linac
2020 · External reference
Comparison of online adaptive and non-adaptive magnetic resonance image-guided radiation therapy in prostate cancer using dose accumulation
2024 · External reference
Prostate volume variation during 1.5T MR-guided adaptive stereotactic body radiotherapy (SBRT) and correlation with treatment toxicity
10.1016/j.radonc.2023.110043 · 2024 · External reference
Ultrahypofractionated radiotherapy for localised prostate cancer: the impact of daily MRI-guided adaptive radiotherapy on delivered dose
2025 · External reference
